Understanding, preventing, and delaying EGFR resistance in the era of Osimertinib

Описание к видео Understanding, preventing, and delaying EGFR resistance in the era of Osimertinib

Earn CME for related activities: https://www.naccme.com/oln

In this presentation from the 23rd Annual Perspectives in Thoracic Oncology, Dr. Lyudmila Bazhenova discusses EGFR resistance in the era of osimertinib.

© 2018 Imedex, an HMP Company

Комментарии

Информация по комментариям в разработке